ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW 1,034.00
+132.00 (14.63%)
Last updated: Jul 21, 2026, 2:02 PM KST
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 53.47 billion as of July 20, 2026. Its market cap has decreased by -38.30% in one year.
Market Cap
53.47B
Enterprise Value
n/a
Revenue
59.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,034.00
ChartMarket Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 53.47B, an increase of 71.39%. That is a compound annual growth rate of 1.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 53.47B | -24.96% |
| Dec 30, 2025 | 71.26B | -61.15% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 104.15B |
| Vaxcell-Bio Therapeutics | 96.40B |
| MedPacto | 92.37B |
| Amicogen | 82.36B |
| iNtRON Biotechnology | 79.35B |
| ENCell | 72.13B |
| CG Invites | 67.97B |
| Prestige BioPharma | 63.58B |